Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential

Marion Polomski(Université de Tours), Gildas Prié(Inserm)
ChemMedChem
December 4, 2020
Cited by 8


Related Papers